Physician profile
Jesse W Stclair
NPI 1477502250
$4,107.19
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,715 · 2020: $1,201 · 2021: $1,192.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $731.60 | 2019-2021 | |
| Amarin Pharma, INC. | $625.08 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $565.84 | 2019-2021 | |
| Amgen INC. | $507.06 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $336.48 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.34 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $229.10 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $157.34 | 2019 | |
| Biotronik INC. | $121.92 | 2019 | |
| Irhythm Technologies, INC. | $84.39 | 2019-2020 | |
| Pfizer INC. | $77.52 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $68.66 | 2019-2021 | |
| Braemar Manufacturing, LLC | $43.21 | 2019 | |
| Merck Sharp & Dohme LLC | $36.78 | 2021 | |
| Portola Pharmaceuticals, LLC | $33.12 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.99 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $24.56 | 2019 | |
| Philips North America LLC | $23.18 | 2020 | |
| Bardy Diagnostics, INC. | $21.47 | 2020 | |
| Nuwellis, INC. | $16.83 | 2019 | |
| Chiesi USA, INC. | $16.45 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $12.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.68 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Stclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.